Stocksigma LogoStocksigma Logo

Aarti Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 82,624 (+26.6% YoY | +17.6% QoQ) ■ EBITDA: 13,536 (+60.6% YoY | +37.9% QoQ) ■ EBITDA Margin (%): 16.4 (+347 bps YoY | +241 bps QoQ) ■ PAT: 8,294

Aarti Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Aarti Drugs Ltd · Financial Result · 04 Nov 2026, 12:33 am

Aarti Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 82,624 (+26.6% YoY | +17.6% QoQ) ■ EBITDA: 13,536 (+60.6% YoY | +37.9% QoQ) ■ EBITDA Margin (%): 16.4 (+347 bps YoY | +241 bps QoQ) ■ PAT: 8,294 (+83.2% YoY | +65.3% QoQ) ■ EPS (INR): 9.07 (+83.2% YoY | +65.2% QoQ)

Original exchange filing (PDF)

More announcements from Aarti Drugs Ltd

All Aarti Drugs Ltd announcements